GenMont Biotech Inc banner

GenMont Biotech Inc
TWSE:3164

Watchlist Manager
GenMont Biotech Inc Logo
GenMont Biotech Inc
TWSE:3164
Watchlist
Price: 18.35 TWD -0.81% Market Closed
Market Cap: NT$1.6B

Wall Street
Price Targets

Price Targets Summary
GenMont Biotech Inc

There are no price targets for GenMont Biotech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
GenMont Biotech Inc Competitors:
Price Targets

Revenue
Forecast

2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Revenue forecast
is not available for
GenMont Biotech Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
GenMont Biotech Inc

Net Income
Forecast

3% / Year
Past Growth
0% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
3% / Year
Past Growth
0% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 14 years the compound annual growth rate for GenMont Biotech Inc's net income is 3%. The projected CAGR for the next 12 years is 0%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GenMont Biotech Inc's stock price target?
Not Available

GenMont Biotech Inc doesn't have any price targets made by Wall Street professionals.

What is GenMont Biotech Inc's Net Income forecast?
Projected CAGR
0%

For the last 14 years the compound annual growth rate for GenMont Biotech Inc's net income is 3%. The projected CAGR for the next 12 years is 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett